Nautilus Biotechnology, Inc. (NAUT) Q4 2024 Annual Earnings
NAUT·Reported February 26, 2025·Before market open
Nautilus Biotechnology, Inc. reported Q4 2024 revenue of $9.6M. Diluted EPS came in at $-0.14, beat the $-0.16 consensus by $0.02.
Revenue
$9.6M
Diluted EPS
$-0.14beat by $0.02
Consensus: $-0.16
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Nautilus Biotechnology, Inc.'s Q4 2024 earnings report.
Nautilus Biotechnology, Inc. (NAUT) reported Q4 2024 earnings on February 26, 2025 before market open.
Nautilus Biotechnology, Inc. reported revenue of $9.6M and diluted EPS of $-0.14 for Q4 2024.
EPS beat the consensus estimate of $-0.16 by $0.02.
You can read the 8-K earnings release (0001808805-25-000004) and the 10-K periodic report (0001808805-25-000008) directly on SEC EDGAR. The filing index links above go to sec.gov.